OrganiGram Holdings Inc

OGI

1.255USD

-0.055-4.20%

Close 03/30, 16:00（ET）Quotes delayed by 15 min

OrganiGram Holdings Inc's Score

Industry at a Glance

Industry Ranking

60 / 75

Overall Ranking

445 / 4542

Industry

Healthcare Providers & Services

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Neutral

OrganiGram Holdings Inc Highlights

StrengthsRisks

Organigram Global Inc. is focused on producing cannabis for adult recreational consumers, as well as developing international business partnerships. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT, Collective Project, Fetch and DEBUNK. It operates facilities in Moncton, New Brunswick and LacSuperieur, Quebec, with an edibles manufacturing facility in Winnipeg, Manitoba. It operates two additional cannabis processing facilities in Southwestern Ontario: one in Aylmer and the other in London. The facility in Aylmer houses CO2 and Hydrocarbon extraction capabilities, and is optimized for formulation refinement, post-processing of minor cannabinoids, and pre-roll production. The facility in London is optimized for labeling, packaging, and national fulfillment. Its subsidiaries include Organigram Inc. and Motif Labs Ltd.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 55.42% year-on-year.

Overvalued

The company’s latest PE is 11.52, at a high 3-year percentile range.

Institutional Selling

The latest institutional holdings are 10.50M shares, decreasing 41.95% quarter-over-quarter.

Higher Market Activity

The company has more investor interest, with a 20-day turnover ratio of -0.15.

Analyst Rating

Based on 0 analysts

--

Current Rating

0.000

Target Price

0.00%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

The current financial score of OrganiGram Holdings Inc is 5.69, ranking 66 out of 75 in the Healthcare Providers & Services industry. Its financial status is weak, and its operating efficiency is low. Its latest quarterly revenue reached 46.89M, representing a year-over-year increase of 56.74%, while its net profit experienced a year-over-year increase of 191.69%.

Score

Industry at a Glance

Previous score

5.69

Change

0



Financials

5.66

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

5.65

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

5.67

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

4.36

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.11

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

The current valuation score of OrganiGram Holdings Inc is 6.05, ranking 59 out of 75 in the Healthcare Providers & Services industry. Its current P/E ratio is 11.52, which is 1794.02% below the recent high of 218.17 and 654.78% above the recent low of -63.90.

Score

Industry at a Glance

Previous score

6.05

Change

0

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 60/75

Relevant data have not been disclosed by the company yet.

No earnings forecast score is currently available for OrganiGram Holdings Inc. The Healthcare Providers & Services industry's average is 7.54.

Score

Industry at a Glance

Previous score

0.00

Change

0

Support & Resistance

Relevant data have not been disclosed by the company yet.

No Data

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

The current price momentum score of OrganiGram Holdings Inc is 6.43, ranking 51 out of 75 in the Healthcare Providers & Services industry. Currently, the stock price is trading between the resistance level at 1.46 and the support level at 1.23, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.23

Change

0.2

Support & Resistance

Relevant data have not been disclosed by the company yet.

Institutional Confidence

Currency: USD Updated: 2026-03-27

Score

Industry at a Glance

Previous score

3.00

Change

0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

British American Tobacco plc

40.13M

+23.22%

Tidal Investments LLC

2.34M

-11.48%

Renaissance Technologies LLC

Star Investors

981.45K

-3.41%

Two Sigma Investments, LP

524.88K

+1376.47%

AdvisorShares Investments, LLC

1.05M

+31.16%

Global X Investments Canada Inc.

1.07M

--

Citadel Advisors LLC

240.63K

-27.29%

Goldman Sachs & Company, Inc.

230.51K

+84.30%

Jane Street Capital, L.L.C.

220.93K

--



1

2



The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Providers & Services domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of OrganiGram Holdings Inc is 3.09, ranking 59 out of 75 in the Healthcare Providers & Services industry. The company's beta value is 1.85. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. with an industry-leading ESG disclosure.

OrganiGram Holdings Inc

OGI

4.23 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Brightspring Health Services Inc

BTSG

8.21 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Encompass Health Corp

EHC

8.10 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Pediatrix Medical Group Inc

MD

8.09 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Viemed Healthcare Inc

VMD

8.07 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Ensign Group Inc

ENSG

8.06 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment